NAMS Menopause Certification Exam (MSCP)
2027–2028: 200 Practice Questions with Verified
Answers & Rationales — Menopause Society
Certified Practitioner Test Bank
Domain 1: Physiology and Pathophysiology of the Menopause
Transition (Questions 1–38)
1. Which term best describes the broad period of endocrine, somatic,
and psychological changes surrounding the menopause transition?
A. Menopause
B. Climacteric
C. Perimenopause
D. Postmenopause
Answer: B. Climacteric.
Rationale: The climacteric encompasses the entire transition from
reproductive to non-reproductive status, including perimenopause and the
early postmenopausal years. It is broader than perimenopause, which refers
specifically to the late reproductive years through 12 months after the final
menstrual period.
2. According to STRAW+10, which finding defines the early
menopause transition (Stage −2)?
A. 60 or more consecutive days of amenorrhea
B. A persistent difference of ≥7 days in the length of consecutive cycles
C. Complete cessation of menses for 12 months
D. Regular cycles of 26–35 days
Answer: B. A persistent difference of ≥7 days in the length of
consecutive cycles.
Rationale: Stage −2 is characterized by increasing cycle variability,
,specifically a persistent difference of 7 or more days in consecutive cycle
lengths. This marks the onset of the menopause transition.
3. Which hormone is the first to decline measurably during the
menopause transition?
A. Estradiol
B. Inhibin B
C. FSH
D. Progesterone
Answer: B. Inhibin B.
Rationale: Inhibin B, produced by small antral follicles, declines earliest as
the follicular pool diminishes. Loss of inhibin B–mediated negative feedback
contributes to the initial rise in FSH before estradiol levels fall substantially.
4. A 44-year-old woman has had no menses for 10 months. Pregnancy
testing is negative. Which diagnosis must be excluded before
attributing amenorrhea to natural menopause?
A. Polycystic ovary syndrome
B. Premature ovarian insufficiency
C. Thyroid dysfunction
D. All of the above
Answer: D. All of the above.
Rationale: Amenorrhea before age 45 warrants evaluation for secondary
causes, including POI, thyroid disease, hyperprolactinemia, and PCOS. POI is
defined as loss of ovarian function before age 40, but evaluation is
appropriate in women under 45 with unexplained amenorrhea.
5. What is the defining age threshold for premature ovarian
insufficiency (POI)?
A. Final menstrual period before age 40
B. Final menstrual period before age 45
C. Final menstrual period before age 50
D. Final menstrual period before age 55
,Answer: A. Final menstrual period before age 40.
Rationale: POI is defined as loss of ovarian function before age 40. Early
menopause is defined as final menstrual period between ages 40 and 45.
6. Which statement best describes the “timing hypothesis” for
menopausal hormone therapy (MHT) and cardiovascular risk?
A. MHT increases CHD risk at any age due to prothrombotic effects.
B. MHT initiated within 10 years of menopause or before age 60 is
associated with reduced or neutral CHD risk, whereas later initiation may
not confer benefit.
C. The timing hypothesis has been refuted; age at initiation does not
modify outcomes.
D. Only transdermal estradiol demonstrates a timing effect.
Answer: B. MHT initiated within 10 years of menopause or before age
60 is associated with reduced or neutral CHD risk, whereas later
initiation may not confer benefit.
Rationale: WHI subgroup analyses and the ELITE trial support the timing
hypothesis: estrogen initiated in the early postmenopausal window is
associated with favorable or neutral cardiovascular effects, while initiation
remote from menopause may lack benefit or increase risk.
7. Which ovarian structure is the primary source of estradiol during the
reproductive years?
A. Primordial follicles
B. Corpus luteum
C. Granulosa cells of antral follicles
D. Ovarian stroma
Answer: C. Granulosa cells of antral follicles.
Rationale: Granulosa cells aromatize androgens to estradiol under FSH
stimulation. The corpus luteum primarily produces progesterone; stromal
cells produce androgens.
, 8. A 38-year-old woman undergoes bilateral oophorectomy for benign
disease. How does her menopause differ from spontaneous
menopause?
A. It is more gradual.
B. It is associated with lower FSH levels.
C. It is abrupt and associated with more severe symptoms.
D. It carries a lower risk of osteoporosis.
Answer: C. It is abrupt and associated with more severe symptoms.
Rationale: Surgical menopause causes an abrupt loss of ovarian hormones,
often producing more acute and severe vasomotor symptoms and a more
rapid decline in bone density than spontaneous menopause.
9. Which statement about fertility during the menopause transition is
correct?
A. Ovulation ceases entirely once cycles become irregular.
B. Fertility is unchanged until the final menstrual period.
C. Fertility declines but pregnancy remains possible until menopause is
established.
D. Fertility increases because of rising FSH.
Answer: C. Fertility declines but pregnancy remains possible until
menopause is established.
Rationale: Although fecundability declines with age and cycle irregularity,
ovulation can still occur intermittently. Contraception remains necessary
until menopause is definitively established.
10. What is the primary pathophysiologic mechanism of vasomotor
symptoms (VMS)?
A. Elevated estrogen directly stimulating sweat glands.
B. Estrogen deficiency narrowing the hypothalamic thermoregulatory set
point.
C. Excess progesterone causing CNS instability.
D. Rising FSH directly activating the adrenal gland.
2027–2028: 200 Practice Questions with Verified
Answers & Rationales — Menopause Society
Certified Practitioner Test Bank
Domain 1: Physiology and Pathophysiology of the Menopause
Transition (Questions 1–38)
1. Which term best describes the broad period of endocrine, somatic,
and psychological changes surrounding the menopause transition?
A. Menopause
B. Climacteric
C. Perimenopause
D. Postmenopause
Answer: B. Climacteric.
Rationale: The climacteric encompasses the entire transition from
reproductive to non-reproductive status, including perimenopause and the
early postmenopausal years. It is broader than perimenopause, which refers
specifically to the late reproductive years through 12 months after the final
menstrual period.
2. According to STRAW+10, which finding defines the early
menopause transition (Stage −2)?
A. 60 or more consecutive days of amenorrhea
B. A persistent difference of ≥7 days in the length of consecutive cycles
C. Complete cessation of menses for 12 months
D. Regular cycles of 26–35 days
Answer: B. A persistent difference of ≥7 days in the length of
consecutive cycles.
Rationale: Stage −2 is characterized by increasing cycle variability,
,specifically a persistent difference of 7 or more days in consecutive cycle
lengths. This marks the onset of the menopause transition.
3. Which hormone is the first to decline measurably during the
menopause transition?
A. Estradiol
B. Inhibin B
C. FSH
D. Progesterone
Answer: B. Inhibin B.
Rationale: Inhibin B, produced by small antral follicles, declines earliest as
the follicular pool diminishes. Loss of inhibin B–mediated negative feedback
contributes to the initial rise in FSH before estradiol levels fall substantially.
4. A 44-year-old woman has had no menses for 10 months. Pregnancy
testing is negative. Which diagnosis must be excluded before
attributing amenorrhea to natural menopause?
A. Polycystic ovary syndrome
B. Premature ovarian insufficiency
C. Thyroid dysfunction
D. All of the above
Answer: D. All of the above.
Rationale: Amenorrhea before age 45 warrants evaluation for secondary
causes, including POI, thyroid disease, hyperprolactinemia, and PCOS. POI is
defined as loss of ovarian function before age 40, but evaluation is
appropriate in women under 45 with unexplained amenorrhea.
5. What is the defining age threshold for premature ovarian
insufficiency (POI)?
A. Final menstrual period before age 40
B. Final menstrual period before age 45
C. Final menstrual period before age 50
D. Final menstrual period before age 55
,Answer: A. Final menstrual period before age 40.
Rationale: POI is defined as loss of ovarian function before age 40. Early
menopause is defined as final menstrual period between ages 40 and 45.
6. Which statement best describes the “timing hypothesis” for
menopausal hormone therapy (MHT) and cardiovascular risk?
A. MHT increases CHD risk at any age due to prothrombotic effects.
B. MHT initiated within 10 years of menopause or before age 60 is
associated with reduced or neutral CHD risk, whereas later initiation may
not confer benefit.
C. The timing hypothesis has been refuted; age at initiation does not
modify outcomes.
D. Only transdermal estradiol demonstrates a timing effect.
Answer: B. MHT initiated within 10 years of menopause or before age
60 is associated with reduced or neutral CHD risk, whereas later
initiation may not confer benefit.
Rationale: WHI subgroup analyses and the ELITE trial support the timing
hypothesis: estrogen initiated in the early postmenopausal window is
associated with favorable or neutral cardiovascular effects, while initiation
remote from menopause may lack benefit or increase risk.
7. Which ovarian structure is the primary source of estradiol during the
reproductive years?
A. Primordial follicles
B. Corpus luteum
C. Granulosa cells of antral follicles
D. Ovarian stroma
Answer: C. Granulosa cells of antral follicles.
Rationale: Granulosa cells aromatize androgens to estradiol under FSH
stimulation. The corpus luteum primarily produces progesterone; stromal
cells produce androgens.
, 8. A 38-year-old woman undergoes bilateral oophorectomy for benign
disease. How does her menopause differ from spontaneous
menopause?
A. It is more gradual.
B. It is associated with lower FSH levels.
C. It is abrupt and associated with more severe symptoms.
D. It carries a lower risk of osteoporosis.
Answer: C. It is abrupt and associated with more severe symptoms.
Rationale: Surgical menopause causes an abrupt loss of ovarian hormones,
often producing more acute and severe vasomotor symptoms and a more
rapid decline in bone density than spontaneous menopause.
9. Which statement about fertility during the menopause transition is
correct?
A. Ovulation ceases entirely once cycles become irregular.
B. Fertility is unchanged until the final menstrual period.
C. Fertility declines but pregnancy remains possible until menopause is
established.
D. Fertility increases because of rising FSH.
Answer: C. Fertility declines but pregnancy remains possible until
menopause is established.
Rationale: Although fecundability declines with age and cycle irregularity,
ovulation can still occur intermittently. Contraception remains necessary
until menopause is definitively established.
10. What is the primary pathophysiologic mechanism of vasomotor
symptoms (VMS)?
A. Elevated estrogen directly stimulating sweat glands.
B. Estrogen deficiency narrowing the hypothalamic thermoregulatory set
point.
C. Excess progesterone causing CNS instability.
D. Rising FSH directly activating the adrenal gland.
